-
The American Society of Clinical Oncology (ASCO) is one of the most noteworthy events in the global biotech industry as it provides an opportunity to gauge the clinical success of pipelines for pharmaceuticals on the global stage. This is the third in a series of articles Korea Biomedical Review publishes to present the key clinical outcomes and development strategies of Korean companies participa
ASCO 2020 Highlights
Shim Hyun-tai
2020.06.02 16:17
-
The American Society of Clinical Oncology (ASCO) is one of the most noteworthy events in the global biotech industry as it provides an opportunity to gauge the clinical success of pipelines for pharmaceuticals on the global stage. This is the second in a series of articles Korea Biomedical Review publishes to present the key clinical outcomes and development strategies of Korean companies particip
ASCO 2020 Highlights
Lee Han-soo
2020.06.02 11:13
-
The American Society of Clinical Oncology (ASCO) is one of the most noteworthy events in the global biotech industry as it provides an opportunity to gauge the clinical success of pipelines for pharmaceuticals on the global stage. This is the first in a series of articles Korea Biomedical Review will publish to present the key clinical outcomes and development strategies of Korean companies partic
ASCO 2020 Highlights
Lee Han-soo
2020.06.01 16:06
-
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. Korea has also emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review, on the occasion of its third anniversary, met with up-and-coming CEOs from various healthcare startu
Special Series in Celebration of KBR’s 4th Anniversary
Shim Hyun-tai
2020.03.20 17:01
-
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. Korea has also emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review, on the occasion of its third anniversary, met with up-and-coming CEOs from various healthcare startu
Special Series in Celebration of KBR’s 4th Anniversary
Lee Han-soo
2020.03.19 15:05
-
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. Korea has also emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review, on the occasion of its third anniversary, met with up-and-coming CEOs from various healthcare startu
Special Series in Celebration of KBR’s 4th Anniversary
Lee Han-soo
2020.03.18 09:10
-
With China-originated new coronavirus (COVID-19) sweeping the entire globe, Korea’s quick and extensive testing capability is drawing the world’s attention. The nation’s remarkably fast and massive testing is attributed to the early development and release of COVID-19 testing kits by domestic in vitro diagnostics companies. How did Korean firms build capacity to develop and roll out testing k
Special Series in Celebration of KBR’s 4th Anniversary
Park Gi-taek
2020.03.17 14:15
-
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. Korea has also emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review, on the occasion of its third anniversary, met with up-and-coming CEOs from various healthcare startu
Special Series in Celebration of KBR’s 4th Anniversary
Lee Han-soo
2020.03.17 09:31
-
It was at 2 a.m. Sunday, but young people were filling bars and clubs in Seoul’s Itaewon area, enjoying their weekend outings despite the new coronavirus.People, mostly in their 20s, made a long queue in front of the entrance of a club nearby the Itaewon Subway Station in the wee hours. At the door, a guard checked entrants' body temperature and whether they were wearing a mask. Once inside th
Special Series in Celebration of KBR’s 4th Anniversary
Shim Hyun-tai
2020.03.16 17:55
-
The new coronavirus is adversely affecting the Korean economy now, and its impacts will be far broader and longer than those of previous epidemics, economic analysts here said on Monday.Last week, when the U.S. stock markets had to halt trading no fewer than three times, the Seoul bourse also took similar steps as investor sentiment plummeted.U.S. President Donald Trump's address last Thur
Special Series in Celebration of KBR’s 4th Anniversary
Lee Han-soo
2020.03.16 12:03
-
The global healthcare sector is being immersed more and more by the Fourth Industrial Revolution. Korea has also emerged as a “technology powerhouse” as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review, on the occasion of its third anniversary, met with up-and-coming CEOs from various healthcare startu
Special Series in Celebration of KBR’s 4th Anniversary
Lee Han-soo
2020.03.16 09:38
-
Korea's medical and pharmaceutical industries have reached a global level over the past years. Such exponential growth has made the country one of the major players in the world participating in global researches jointly with multinational companies. Against this backdrop, Korea Biomedical Review ha
Interview with global pharma
Lee Han-soo
2020.03.11 15:41
-
The U.S. International Trade Commission is soon to make a ruling that will determine whether the No. 1 botulinum toxin (BTX) maker Allergan will be able to maintain its 70 percent market share in the U.S. Last year, Korean BTX manufacturer Medytox and its U.S. partner Allergan filed a complaint with the ITC that Daewoong Pharmaceutical and its partner firm Evolus stole the strain of Medytox’s botu
Special
Park Gi-taek
2020.02.28 15:27
-
The Korean government recently lifted the alert level to the highest in the four-tiered system to prevent the spread of the new coronavirus, but some critics said the move was too hasty. Critics said China, where the first confirmed case of the COVID-19 infection occurred, did not declare the highest alert level across the country. Just because new confirmed cases spiked centering mostly on th
Special
Special Reporting Team
2020.02.28 13:07
-
In the wake of the ranitidine recall, other antiulcer “tidine-class” drugs, proton-pump inhibitors (PPIs), and various mucosal protective agents have enjoyed sales growth, industry data showed.Artemisia extract-based drugs, led by Dong-A ST’s Stillen Tab., recorded a particularly rapid sales expansion in two months after the ranitidine ban. According to U-BIST data, sales of antiulcer med
Special
Jeong Sae-im
2020.01.07 16:12
-
Investors are rushing to bet on new drug development, which is often called the goose that lays golden eggs. The government picked the biohealth industry as one of the future growth industries and vowed to support the sector aggressively. In this situation, many domestic drugmakers and biotech venture firms increasingly joined new drug development to target the global market. However, some compani
Special
Kim Yun-mi
2020.01.02 17:30
-
As an online video claiming that dog dewormer fenbendazole could cure cancer went viral, cancer patients conducted “voluntary clinical trials,” trying the canine treatment on themselves in desperate hope. The medical industry had significant legal issues, including the Constitutional Court’s ruling that the 66-year-old anti-abortion law was unconstitutional. Hospitals suffered the worst shortage o
Special
Kwak Sung-sun
2019.12.31 13:33
-
This year was a year where the word "safety" was particularly highlighted in the healthcare industry. The N-Nitrosodimethylamine (NDMA), a potentially carcinogenic substance, which caused a ruckus after being detected in valsartan-based antihypertensive treatment last year, was further extended to ranitidine and nizatidine. Earlier this month, the medical community was startled when the carcinogen
Special
Kim Yun-mi
2019.12.31 11:14
-
As an online video claiming that dog dewormer fenbendazole could cure cancer went viral, cancer patients conducted “voluntary clinical trials,” trying the canine treatment on themselves in desperate hope. The medical industry had significant legal issues, including the Constitutional Court’s ruling that the 66-year-old anti-abortion law was unconstitutional. Hospitals suffered the worst shortage o
Special
Kwak Sung-sun
2019.12.31 10:28
-
This year was a year where the word "safety" was particularly highlighted in the healthcare industry. The N-Nitrosodimethylamine (NDMA), a potentially carcinogenic substance, which caused a ruckus after being detected in valsartan-based antihypertensive treatment last year, was further extended to ranitidine and nizatidine. Earlier this month, the medical community was startled when the carcinogen
Special
Park Gi-taek
2019.12.31 09:25
